All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
CHINA SXT PHARMACEUTICALS, INC. Last Reported: 3/31/2023 Stock Symbol:

Business Address

178 TAIDONG ROAD NORTH

TAIZHOU , CN 225300

Mailing Address

178 TAIDONG ROAD NORTH

TAIZHOU , CN 225300
Phone Number: 8652386298290 / State Incorporated: / Fiscal Year End 3 /31

Balance Sheet

Date 3/31/2023 5/31/2022 3/31/2022 3/31/2021 9/30/2020 3/31/2020 9/30/2019 3/31/2019 9/30/2018 3/31/2018 3/31/2017 3/31/2016
Cash and Cash Equivalents -- -- -- $13,358,975.00 $10,353,474.00 $7,287,032.00 $8,247,069.00 $9,130,849.00 $383,606.00 $560,252.00 $65,570.00 $11,439.00
Accounts Receivable Net Current $1,344,569.00 -- $3,333,178.00 $4,507,115.00 $5,579,564.00 $3,819,437.00 $4,568,123.00 $4,180,559.00 -- $2,602,597.00 -- --
Inventory $531,254.00 -- $1,017,527.00 $859,696.00 $867,281.00 $892,767.00 $846,281.00 $1,007,918.00 -- $1,266,880.00 -- --
Prepaid Expenses and Other Current Assets $230,642.00 -- $864,709.00 $1,859,103.00 $2,174,229.00 $4,618,740.00 $2,022,769.00 $707,337.00 -- $910,606.00 -- --
Total Current Assets $19,521,247.00 -- $22,451,855.00 $23,233,476.00 $22,059,206.00 $19,636,313.00 $17,542,342.00 $15,588,100.00 -- $6,102,190.00 -- --
Property Plant and Equipement $962,214.00 -- $1,227,811.00 $1,433,479.00 $1,462,636.00 $1,574,602.00 $1,759,907.00 $1,158,898.00 -- $862,453.00 -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $29,554,056.00 -- $33,546,273.00 $34,547,602.00 $24,042,871.00 $21,702,178.00 $23,045,943.00 $17,470,833.00 -- $7,657,894.00 -- --
Accounts Payable $1,377,850.00 -- $1,482,192.00 $1,456,445.00 $1,358,568.00 $1,941,151.00 $1,959,426.00 $1,685,419.00 -- $2,407,359.00 -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $14,862,761.00 -- $17,121,565.00 $18,586,195.00 $5,521,668.00 $12,300,825.00 $11,636,808.00 $6,363,078.00 -- $4,372,119.00 -- --
Long Term Debt -- -- -- $6,292.00 $15,213.00 $36,511.00 $55,052.00 $41,706.00 -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-197,571.00 -- $956,142.00 $527,786.00 $48,115.00 $-590,660.00 $-756,920.00 $50,395.00 -- $257,373.00 -- --
Accumulated Deficit $-21,613,133.00 -- $-15,688,278.00 $-9,952,183.00 $-5,822,742.00 $-7,204,000.00 $735,803.00 $3,083,872.00 -- $1,544,645.00 -- --
Total Stockholders' Equity $14,691,295.00 -- $16,424,708.00 $15,961,407.00 $18,521,203.00 $9,401,353.00 $11,409,135.00 $11,107,755.00 $4,601,895.00 $3,285,775.00 $1,852,646.00 $742,767.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $29,554,056.00 -- $33,546,273.00 $34,547,602.00 $24,042,871.00 $21,702,178.00 $23,045,943.00 $17,470,833.00 -- $7,657,894.00 -- --

Statement of Operations

Date 3/31/2023 5/31/2022 3/31/2022 3/31/2021 9/30/2020 3/31/2020 9/30/2019 3/31/2019 9/30/2018 3/31/2018 3/31/2017 3/31/2016
Total Revenues $1,971,679.00 -- $2,602,281.00 $4,777,573.00 $3,860,501.00 $5,162,268.00 $3,215,147.00 $7,012,026.00 $3,917,707.00 $7,019,243.00 $4,881,523.00 --
Cost of Revenues $1,545,408.00 -- $1,350,638.00 $1,938,023.00 $1,039,565.00 $2,458,566.00 $1,375,762.00 $2,400,491.00 $1,239,023.00 $3,617,748.00 $2,569,522.00 --
Gross Profit $426,271.00 -- $1,251,643.00 $2,839,550.00 $2,820,936.00 $2,703,702.00 $1,839,385.00 $4,611,535.00 $2,678,684.00 $3,401,495.00 $2,312,001.00 --
Research and Development -- -- -- -- -- -- -- -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $6,033,780.00 -- $6,441,316.00 $5,036,626.00 $1,657,126.00 $4,044,819.00 $2,060,138.00 $2,842,043.00 $1,351,749.00 $1,769,229.00 $709,819.00 --
Loss from Operations $-5,607,509.00 -- $-5,189,673.00 $-2,197,076.00 $1,163,810.00 $-1,341,117.00 $-220,753.00 $1,769,492.00 $1,326,935.00 $1,632,266.00 $1,602,182.00 --
Loss Before Income Taxes -- -- $-5,407,949.00 $-2,940,866.00 -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.89 -- $5.52 -- -- -- $-0.10 $0.08 $0.05 $0.06 $0.06 --
Weighted Average Shares Basic 6,674,327 -- 1,039,766 -- -- -- 22,725,512 20,568,630 20,000,000 20,000,000 20,000,000 --
Earnings Per Share Diluted $-0.89 -- -- -- -- -- $-0.10 $0.08 $0.05 $0.06 $0.06 --
Weighted Average Shares Diluted 6,674,327 -- -- -- -- -- 22,725,512 20,568,630 20,000,000 20,000,000 20,000,000 --
Common Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Outstanding 11,434,129 -- 2,031,394 15,525,094 62,057,584 34,667,707 23,224,866 22,706,701 -- 20,000,000 -- --
Common Stock Value $913,785.00 -- $162,468.00 $62,057.00 $62,057.00 $34,667.00 $23,224.00 $22,706.00 -- $20,000.00 -- --
Common Stock Par Or Stated Value Per Share $0.08 $0.08 $0.08 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com